Gefapixant (Lyfnua)
Refractory or Unexplained Chronic Cough
ApprovedCommercial
Key Facts
Indication
Refractory or Unexplained Chronic Cough
Phase
Approved
Status
Commercial
Company
About KYORIN Pharmaceutical
KYORIN Pharmaceutical is a mid-sized, revenue-generating Japanese pharmaceutical company with a diversified portfolio spanning prescription drugs, over-the-counter (OTC) products, and veterinary medicines. The company leverages its expertise in respiratory and urological diseases to maintain a stable revenue base from commercial products while investing in R&D for future growth. Its strategic focus includes lifecycle management of key brands and advancing its pipeline through internal research and selective partnerships.
View full company profile